These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 286686

  • 1. Blastic transformation in chronic granulocytic leukaemias.
    J Assoc Physicians India; 1978 Dec; 26(12):1165-7. PubMed ID: 286686
    [No Abstract] [Full Text] [Related]

  • 2. [A case of chronic myelocytic leukemia (CML) with terminal manifestation of acute promyelocytic leukemia (author's transl)].
    Matsuda S, Igarashi T, Kimura H, Muroi S, Tanaka T, Uchida T, Kariyone S.
    Rinsho Ketsueki; 1980 Sep; 21(9):1401-7. PubMed ID: 6935450
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Pericardial infiltration during the blastic transformation phase of chronic granulocytic leukemia].
    Iványi JL, Kiss A, Jakó J.
    Orv Hetil; 1979 Jun 24; 120(25):1519-24. PubMed ID: 289091
    [No Abstract] [Full Text] [Related]

  • 6. Cytotoxicity of lymphocytes and antibodies against autologous tumor cells in patients with myeloid leukaemias and preleukaemic disorders. III. Stage-dependence of oncovirus-specific immune response.
    Szabó B, Tóth FD, Váczi L, Kiss J, Réthy A, Kiss A, Rák K.
    Acta Microbiol Hung; 1986 Jun 24; 33(2):103-10. PubMed ID: 3492851
    [Abstract] [Full Text] [Related]

  • 7. Blastic transformation in chronic granulocytic leukaemia.
    Singh VP, Dube B, Dube RK, Srivastava AK, Sahu BB, Bajpai HS, Das SK.
    J Assoc Physicians India; 1984 May 24; 32(5):417-9. PubMed ID: 6594326
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cytotoxic activity of lymphocyte subpopulations against autologous tumour cells in patients with myeloid leukaemias and preleukaemic disorders.
    Szabó B, Váczi L, Tóth FD, Kiss J, Kiss A, Rák K.
    Acta Microbiol Hung; 1988 May 24; 35(1):25-33. PubMed ID: 3260709
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Chromosomal abnormalities of the blastic phase of chronic myeloid leukemia].
    Stoll C.
    Pathol Biol (Paris); 1982 Nov 24; 30(9):755-8. PubMed ID: 6760078
    [Abstract] [Full Text] [Related]

  • 15. Extra-medullary blastic transformation in remission phase of chronic granulocytic leukaemia.
    Singh VP, Dube B, Bajpai HS, Dube RK, Pant GC.
    J Assoc Physicians India; 1978 Dec 24; 26(12):1177-9. PubMed ID: 286687
    [No Abstract] [Full Text] [Related]

  • 16. Clinical usefulness of immunological marker analysis in adult patients with acute leukaemia.
    Van 't Veer MB, Tetteroo PA, Von dem Borne KR, Engelfriet CP.
    Neth J Med; 1985 Dec 24; 28(3):124-7. PubMed ID: 3856755
    [No Abstract] [Full Text] [Related]

  • 17. Analysis of immunophenotype, genotype, and lineage fidelity in blastic transformation of chronic myelogenous leukemia: a study of 20 cases.
    Adachi K, Okumura M, Tanimoto M, Morishima Y, Ohno R, Saito H.
    J Lab Clin Med; 1988 Jan 24; 111(1):125-32. PubMed ID: 3422082
    [Abstract] [Full Text] [Related]

  • 18. [A case of chronic granulocytic leukemia with 3 types of abnormal chromosomes in addition to Ph1) chromosome at the blastic crisis (author's transl)].
    Kohsaki M, Semba M, Nagai K, Kai S, Hara H, Sonoda Y, Abe T.
    Rinsho Ketsueki; 1980 Nov 24; 21(11):1767-72. PubMed ID: 6937696
    [No Abstract] [Full Text] [Related]

  • 19. [Morphological and clinical variants of blastic crisis in chronic myeloid leukemia].
    Burchardt K.
    Pol Arch Med Wewn; 1979 Oct 24; 62(4):357-64. PubMed ID: 388368
    [No Abstract] [Full Text] [Related]

  • 20. Monoclonal antibody against myeloid leukemia cell line (KG-1).
    Aota F, Chang D, Hill NO, Khan A.
    Cancer Res; 1983 Mar 24; 43(3):1093-6. PubMed ID: 6572095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.